Abstract: A dental implant in which an external thread structure of the implant and an internal polygonal part structure are improved, thereby being capable of preventing a fatigue fracture caused by stress concentration at a portion adjacent to the polygonal part inside the implant. The dental implant implantable into an alveolar bone tissue and forming an artificial tooth root includes an external bottom thread section machined up to a predetermined section upward from a bottom of an outer peripheral surface of the implant so that threads having large heights are formed by a first bit, and includes an external top thread section machined above the external bottom thread section so that threads having small heights are formed by a second bit having a different machining surface shape and a different width. The threads of each thread section have the same pitches and the same crest widths.

Abstract: The present invention relates to a food composition for relieving stress, and specifically, to a food composition for relieving stress, which reduces secretion of the stress hormone cortisol and increases secretion of the happy hormone serotonin by containing fermented and aged noni and calamansi as active ingredients, has no side effects, and is safe for the human body. The composition of the present invention may be used as a health functional food or a pharmaceutical composition. The composition of the present invention has an excellent anti-stress effect.

Abstract: An exemplary embodiment of the present invention provides a deployable solar panel mounted on a movable body configured to be movable, the deployable solar panel including: a solar panel mounted on an outer portion of the movable body and configured to convert light energy into electrical energy; and a yoke having a reinforcing part stacked on at least one surface of a base to connect the movable body and the solar panel and configured to attenuate vibration transmitted to the solar panel.

Abstract: Disclosed is a method of reducing surface unevenness of a semiconductor wafer (100). In a preferred embodiment, the method comprises: removing a portion of a deposited layer and a protective layer thereon using a first slurry to provide an intermediate surface (1123). In the described embodiment, the deposited layer includes an epitaxial layer (112) and the protective layer includes a first dielectric layer (113). The first slurry includes particles with a hardness level the same as or exceeding that of the epitaxial layer (112). A slurry for use in wafer fabrication for reducing surface unevenness of a semiconductor wafer is also disclosed.

Abstract: Disclosed are a composition including a Pseudomonas sp. strain having excellent plastic degradation activity and the use thereof. The Pseudomonas sp. Strain may include Pseudomonas sp. JNU 01 (Accession No: KCTC 14861BP).

Abstract: The present invention relates to a food composition for enhancing immune function, which includes a fermented noni polysaccharide extract, and a method of preparing the same. The present invention may provide a polysaccharide extract prepared from a fermented noni extract. The present invention may provide a fermented noni polysaccharide extract, in which when the polysaccharide extract aqueous solution is provided at a concentration of 200 ?g/mL to RAW264.7 macrophages, an NO production value is 200% to 500% relative to RAW264.7 macrophages to which the polysaccharide extract solution is not provided.

Abstract: Various systems and methods for implementing end-to-end quality of service (QoS) for network communications are provided using various network and compute technologies. In an example, managing Quality of Service (QoS) for end-to-end network data flows, includes: identifying QoS characteristics for data flows of a user equipment (UE), for data flows performed via multiple access networks; mapping the QoS characteristics to network functions of at least one of the multiple access networks; and controlling the network functions of the at least one of the multiple access networks, based on the QoS characteristics, as the network functions are implemented at respective resources located within at least one of the multiple access networks. Further examples for controlling the network functions using Access Traffic Steering, Switching and Splitting (ATSSS) functionality in an 3GPP multi-access network, and configuring a network exposure function of an 3GPP multi-access network, are also disclosed.

Abstract: A semiconductor device includes an active pattern having a lower pattern, and a plurality of sheet patterns spaced apart from the lower pattern in a first direction; first and second structures disposed on the lower pattern, wherein the first and second structures are arranged and spaced apart from each other in a second direction; a source/drain recess defined between first and second gate structures; and a source/drain pattern filling the source/drain recess, wherein the source/drain pattern includes a stacking fault spaced apart from the lower pattern.

Abstract: The present invention relates to a technology for analyzing and detecting/diagnosing a target nucleic acid. When the detection system according to the present invention is used, effective real-time detection or diagnosis efficiency can be obtained while problems such as noise are minimized. In particular, since, by using a house-keeping gene according to a method of use, the expression difference of the target nucleic acid can be corrected, and direct real-time target nucleic acid detection is possible, it can be effectively used for detecting various nucleic acids and diagnosing various diseases thereby.

Abstract: Methods, apparatus, systems, and articles of manufacture are disclosed for private network mobility management. An example private network in a box includes interface circuitry to communicate with multi-access terrestrial network (TN) nodes and non-terrestrial network (NTN) nodes, machine readable instructions, and programmable circuitry. The example programmable circuitry is to generate a first mesh associated with a geographical area of the private network and a second mesh associated with the geographical area. The example programmable circuitry is also to initiate at least one of the multi-access TN nodes in alignment with the first mesh and at least one of the NTN nodes in alignment with the second mesh. Additionally, the example programmable circuitry is to facilitate communication associated with at least one user equipment within at least one of the first mesh or the second mesh using the private network.

Abstract: The present disclosure relates to a separator for a fuel cell and a manufacturing method of the same. The manufacturing method of the separator for a fuel cell includes: an unevenness forming step of forming a fine-sized unevenness on a surface of a metal base material; and a coating layer forming step of forming a coating layer by coating carbon on the surface of the metal base material on which the unevenness is formed. Through the manufacturing method, it is possible to obtain an effect of improving water discharge performance and adhesion between the metal base material and the coating layer by forming unevenness on a surface of a metal base material, and then forming a coating layer.

Abstract: A method for treating a retinal or choroidal disease including administering a composition containing an actin alpha 2 (ACTA2) inhibitor as an active ingredient to a subject in need. The composition is administered by one or more routes selected from the group consisting of oral, subcutaneous, intraperitoneal, intrapulmonary, intranasal, intramuscular, intravenous, intraarterial and topical ocular administration.

Abstract: A method of ameliorating or treating a retinal or choroidal disease, the method including: administering a composition containing a plasmalemma vesicle-associated protein (PLVAP), an expression or activity activator of the PLVAP protein, or a nucleotide sequence encoding the PLVAP protein, to a subject in need thereof. The composition is formulated for administering to the subject via one or more routes selected from the group consisting of oral, subcutaneous, intraperitoneal, intrapulmonary, intranasal, intramuscular, intravenous, intraarterial and topical ocular administration.

Abstract: The present invention relates to a method for preparing a large animal model, with peritoneal carcinomatosis, which is an abdominal cavity metastasis of tumor commonly found in advanced or recurrent solid cancer, is induced using a large animal, and the method for preparing a large animal model with peritoneal carcinomatosis comprises injecting a cancer cell line into the abdominal cavity of a piglet in which the immune function is not completed. The method for preparing a large animal model with peritoneal carcinomatosis, when a human-derived immortalized cell line is inoculated into a pig, can overcome xenograft rejection and induce peritoneal carcinomatosis, can use animals with sufficient supply and demand, and can expect the spread of peritoneal carcinomatosis through breeding.

Abstract: In one example, a semiconductor device comprises a substrate comprising a conductive structure, a first electronic component over the substrate, an encapsulant over the substrate and contacting a lateral side of the first electronic component, a shield over the encapsulant and contacting a lateral side of the encapsulant and a portion of a lateral side of the substrate, and a communication structure coupled with the substrate. The substrate comprises a vertical groove side and a horizontal groove side defining a groove in the substrate, wherein a portion of the groove is uncovered by the shield. Other examples and related methods are also disclosed herein.

Abstract: The present disclosure provides androgen receptor (AR) and phosphodiesterase 5 (PDE-5) inhibitor compounds of the formula (I): and compositions including said compounds. The compounds can provide dual functionality for inhibiting AR and inhibiting PDE-5. The present disclosure also provides methods of using said compounds and compositions for inhibiting AR and PDE-5 in a biological system or biological sample. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.

Abstract: The present disclosure provides a reagent composition for detecting illicit drugs, the composition comprising: a diacetylene derivative compound represented by chemical formula 1; and at least one compound selected from among gabazine (SR-95531), an amine group-linked diacetylene derivative represented by chemical formula 2-1, and a gabazine-linked diacetylene derivative represented by chemical formula 2-2.

Abstract: Systems, apparatus, articles of manufacture, and methods are disclosed. An example edge compute device disclosed herein includes interface circuitry, machine readable instructions, and programmable circuitry to execute the machine readable instructions to configure compute resources of the edge compute device based on a first resource demand associated with a first location of the edge compute device, detect a change in location of the edge compute device to a second location, and in response to detection of the change in location, reconfigure the compute resources of the edge compute device based on a second resource demand associated with the second location.